Oncogene expression and prognosis in cervical cancer
- 31 August 1991
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 59 (2) , 171-175
- https://doi.org/10.1016/0304-3835(91)90183-i
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvementGynecologic Oncology, 1991
- Development of an immunological staging system to prognosticate disease course in malignant cervical neoplasiaGynecologic Oncology, 1990
- Invasive cervical cancer in the 1990sSeminars in Surgical Oncology, 1990
- Ras Oncogene p21 Levels Parallel Malignant Potential of Different Human Colonic Benign ConditionsArchives of Surgery, 1987
- C-myc PROTO-ONCOGENE EXPRESSION AND PROGNOSIS IN EARLY CARCINOMA OF THE UTERINE CERVIXThe Lancet, 1987
- Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasiaBritish Journal of Cancer, 1987
- The Molecular Genetics of CancerScience, 1987
- c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cellsNature, 1985
- Transforming ras oncogenes and multistage carcinogenesisBritish Journal of Cancer, 1985
- Cure rate estimation and long-term prognosis of uterine cervix carcinomaCancer, 1981